Final Dividend – Pence Sterling Amount Payable

Summary by AI BETAClose X

Rentokil Initial plc has announced that its final dividend for the financial year ending 31 December 2025, originally declared at 8.24 cents per ordinary share, will be payable at 6.10 pence sterling per ordinary share. This conversion to sterling is based on an average exchange rate of GBP1:USD1.3513 determined over three working days commencing 20 April 2026. The dividend is subject to shareholder approval at the AGM on 7 May 2026 and is scheduled to be paid on 18 May 2026 to shareholders on the register as of 10 April 2026.

Disclaimer*

Rentokil Initial PLC
23 April 2026
 

RI_new

 

 

23 April 2026

Rentokil Initial plc

Final Dividend - Pence Sterling Amount Payable

 

 

Rentokil Initial plc (the "Company") announced a final dividend for the financial year ending 31 December 2025 of 8.24 cents per ordinary share on 5 March 2026.

 

The pence sterling amount payable in respect of the final dividend has been determined with reference to the average of the market exchange rates on the three working days commencing 20 April 2026, using the closing spot rate, resulting in an applicable exchange rate of GBP1:USD1.3513. Accordingly, the pence sterling amount payable to shareholders in relation to the final dividend will be 6.10 pence sterling per ordinary share.

 

Subject to shareholder approval at the Annual General Meeting ("AGM") on 7 May 2026, the final dividend will be paid on 18 May 2026 to shareholders on the register at the close of business on 10 April 2026.

 

 

For further information, please contact:

 

Investors / Analysts: Heather Wood, Rentokil Initial plc, +44 7808 098793

Media: Malcolm Padley, Rentokil Initial plc, +44 7788 978199

 

About Rentokil Initial plc:

 

Rentokil Initial plc is a global leader in Pest Control and Hygiene & Wellbeing services. It employs c.63,400 people in 90 countries.

 

www.rentokil-initial.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings